Catalyst Wire Dossier Catalyst Wire Dossier

Bemnifosbuvir/Ruzasvir

bemnifosbuvir/ruzasvir · Atea Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Bemnifosbuvir/Ruzasvir, covering 2024-07-31 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone [Phase 1]

See pricing